Helping patients quit smoking after psychiatric hospitalization
Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization
This study tests a program to help people quit smoking after they leave the hospital for mental health treatment by providing counseling and resources to support their efforts.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Trial ID | NCT05672914 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on promoting smoking cessation among individuals hospitalized for psychiatric disorders. It leverages the enforced no-smoking period during hospitalization as a 'teachable moment' to encourage patients to quit smoking. The approach includes a professionally-led motivational counseling session and a referral to quit smoking resources upon discharge. The goal is to integrate effective smoking cessation strategies into psychiatric treatment settings, addressing the high smoking rates and associated health risks in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are current smokers and capable of providing informed consent.
Not a fit: Patients with cognitive impairments, substance use disorders requiring detoxification, or those who cannot provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the health outcomes and quality of life for patients with psychiatric disorders by helping them quit smoking.
How similar studies have performed: Other studies have shown promise in integrating smoking cessation interventions in psychiatric settings, indicating potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patients above the age of 18 capable of providing informed consent * Current smoker (at least 5 cigarettes/day when not hospitalized) * Willing and able to provide informed consent, attend all study visits, and comply with the protocol Exclusion Criteria: * Mini-Mental State Examination (MMSE) score \< 24 * Current diagnosis of dementia or other cognitive impairment that would limit study participation * Inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures * Current diagnosis of a (non-nicotine) substance use disorder requiring detoxification * No access to or inability to communicate by phone, or no stable mailing address * Planned discharge to institutional care (e.g., nursing home, long-term rehabilitation, jail, etc.) * Medical contraindication to nicotine patch use * Currently pregnant or breastfeeding
Where this trial is running
Austin, Texas
- Ascension Shoal Creek — Austin, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Richard Brown, Ph.D. — The University of Texas at Austin
- Study coordinator: Richard Brown, Ph.D.
- Email: brown2@utexas.edu
- Phone: +1 512 232-6832
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.